[Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting].

4区 医学 Q3 Medicine
Radiologe Pub Date : 2022-03-01 Epub Date: 2022-01-17 DOI:10.1007/s00117-021-00965-6
Thomas J Vogl, Christoph Mader, Sabine Michalik, Renate Hammerstingl, Vitali Koch
{"title":"[Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting].","authors":"Thomas J Vogl,&nbsp;Christoph Mader,&nbsp;Sabine Michalik,&nbsp;Renate Hammerstingl,&nbsp;Vitali Koch","doi":"10.1007/s00117-021-00965-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Clinical/methodical issue: </strong>The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2 cm-continues to be a radiological challenge.</p><p><strong>Standard radiological methods: </strong>In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard.</p><p><strong>Methodological innovations: </strong>HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings.</p><p><strong>Performance: </strong>Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions.</p><p><strong>Achievements: </strong>Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC.</p><p><strong>Practical recommendations: </strong>A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.</p>","PeriodicalId":54513,"journal":{"name":"Radiologe","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiologe","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00117-021-00965-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Clinical/methodical issue: The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2 cm-continues to be a radiological challenge.

Standard radiological methods: In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard.

Methodological innovations: HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings.

Performance: Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions.

Achievements: Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC.

Practical recommendations: A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.

[小肝癌:根据指南进行诊断,并在临床环境中确定]。
临床/方法学问题:肝细胞癌(HCC)的诊断-特别是小病变的特征标准放射学方法:在目前的S3 HCC诊断和治疗指南中,造影增强成像检查,如超声造影(CEUS)、计算机断层扫描(CT)和磁共振成像(MRI)仍然是诊断标准。方法创新:肝硬化肝细胞癌应通过其典型的MRI增强模式诊断。此外,使用LI-RADS(肝脏成像报告和数据系统)等质量保证工具有助于结果的一致性,即使是小的模糊结果。表现:许多研究表明,LI-RADS分级反映了HCC等肝脏恶性病变的可能性。成果:指南和质量保证工具有助于对疑似HCC患者进行更精确的诊断。实用建议:应全面使用符合指南的诊断算法和LI-RADS进行准确的HCC诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiologe
Radiologe 医学-核医学
CiteScore
1.10
自引率
0.00%
发文量
61
审稿时长
6-12 weeks
期刊介绍: Der Radiologe is an internationally recognized journal dealing with all aspects of radiology and serving the continuing medical education of radiologists in clinical and practical environments. The focus is on x-ray diagnostics, angiography computer tomography, interventional radiology, magnet resonance tomography, digital picture processing, radio oncology and nuclear medicine. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信